I have been seeing a lot of talk lately about how "AI will start creating the next AI." This concept is called Recursive Self ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals (RXRX) just moved onto many investors’ radar after Sanofi optioned the first development candidate ...

Fresh off a $150 million IPO, Tom Miller spoke to BioPharma Dive about the roadshow process and how he sees AI’s role in drug ...

Recursion reported two confirmed responses in endometrial cancer and a 91.7% disease-control rate at doses of 45 mg or higher; Sanofi optioned a candidate.

When studying programming, you notice something strange.Processes that are extremely complex for humans to think through can ...

MONTREAL — The next advances in the capabilities of AI could well be made by AI itself, as tech giants and startups automate more machine learning research and development. Many firms are aiming for ...

Gladstone's report says a self-improving AI loop could start in 3 to 12 months. Its funnel model shows that idea volume cannot replace the test compute needed t ...

This advancement could lead to “humans losing control over AI,” one leading AI lab says.

Australia said on Thursday, September 24, that an OpenAI agent breached a government health data portal in June and gained unauthorised access to files. The incident could represent the first known ...

– Cisco and Splunk are exploring a model of “recursive security” in which offensive and defensive AI agents continuously test, evaluate and improve security controls. – Observability is central to ...